Mga Industriya

• Reset all ×
• Mga Agham sa Buhay ×
• Global ×

Showing 81–89 ng mga 89 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Global Rare Disease Diagnostics Market 2021

  A rare disease, also referred to as an orphan disease, is any disease that affects a small percentage of the population. There are thousands of rare diseases. To date, six to seven thousand rare diseases have been discovered and new diseases are regularly described in medical literature. The global rare disease diagnostics market in terms of revenue is set to grow by US$ 12 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 8.6% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Rising burden of diseases and increase in incidence and prevalence of genetic disorders and various types of cancer, increase in adoption of whole genome and exome sequencing, and increasing research funding and surge in usage for new techniques are driving market growth. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the rare disease diagnostics market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 2,750
• 

  Global Ophthalmic Devices Market 2021

  Ophthalmic devices are medical equipment used in the identification and treatment of ocular defects or deficiencies and eye disorders. These devices cover a wide range of design types such as refractors, fundus camera, optical coherence tomography systems, perimeters, slit lamps, and tonometer. The global ophthalmic devices market in terms of revenue is set to grow by US$ 9 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 4.4% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Increasing aging population, rising burden of diseases and increase in incidence and prevalence of ophthalmic diseases are driving market growth. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the ophthalmic devices market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 1,250
• 

  Global Asthma and COPD Devices Market 2021

  Asthma and COPD, including emphysema and chronic bronchitis are inflammatory diseases that cause airflow blockage and breathing-related problems. The global asthma and COPD devices market in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 6.2% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. North America held the highest share in the global asthma and copd devices market, while Asia Pacific is expected to grow at the highest CAGR during the forecast period. Increase in incidence and prevalence of asthma and COPD and growing geriatric population are driving market growth. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the asthma and COPD devices market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 2,250
• 

  Global CEP (Cerebral Embolic Protection) Systems Market 2021

  The global CEP (cerebral embolic protection) systems market in terms of revenue is set to grow by US$ 572 million during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 27% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the CEP (cerebral embolic protection) systems market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 450
• 

  Global Prostate Cancer Drug Market 2021

  The global prostate cancer drug market in terms of revenue is set to grow by US$ 11 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 10.5% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the prostate cancer drug market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 450
• 

  Global Biologics CDMO (Contract Development and Manufacturing Organization) Market 2021

  The global biologics CDMO (contract development and manufacturing organization) market in terms of revenue is set to grow by US$ 22 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 20.3% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the biologics CDMO (contract development and manufacturing organization) market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 450
• 

  Global Heparin API Market 2021

  The global heparin API market in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 6.5% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the heparin API market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 450
• 

  Global Enoxaparin Finished Dose Market 2021

  The global enoxaparin finished dose market in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 5.9% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the enoxaparin finished dose market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 450
• 

  Global Heparin Finished Dose Market 2021

  The global heparin finished dose market in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 5.3% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the heparin finished dose market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

  USD 450